Registered index-linked annuity (RILA) products, such as Aspida’s DreamPath, have been a major driver of this growth. LIMRA data shows that RILA sales set new records in the second quarter of 2025, reaching $19.1 billion, a 15% increase from the previous year. For the first half of 2025, RILA sales totaled $36.7 billion, up 18% year over year.
